The global Carotid Stents Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Material (Metals, Others), By Type (Self-Expanding Stents, Balloon-Expandable Stents), By End-User (Hospitals, Ambulatory Surgical Centers, Cardiac Centers).
The Carotid Stents Market encompasses medical devices used in endovascular procedures to treat carotid artery stenosis and restore blood flow in patients at risk of stroke or cardiovascular complications. Carotid stents are designed to support the arterial walls, prevent blockages, and reduce the risk of embolism in the carotid arteries. In 2024, this market highlights technological advancements in stent design, materials, coatings, and deployment techniques, offering minimally invasive options and improved outcomes for patients undergoing carotid artery interventions.
The global Carotid Stents Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Carotid Stents Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Carotid Stents Industry include- Abbott Laboratories, Impulse Dynamics, Beijing Bomais Technology Development, Biotronik Se & Co. KG, Boston Scientific Corp, Cardinal Health, InspireMD, Medtronic Plc, MicroPort Scientific Corp, Shanghai Haoran Biotechnology Co. Ltd, Shanghai Hengfei Biological Technology Co. Ltd, Shanghai Zhenyu Biological Technology Co. Ltd, Terumo Corp, W. L. Gore & Associates.
A prominent trend in the Carotid Stents market is the increasing adoption of drug-eluting stents (DES) for the treatment of carotid artery disease. DES, coated with anti-restenotic drugs, have shown promising outcomes in reducing the risk of restenosis compared to bare-metal stents (BMS). As clinicians prioritize patient outcomes and seek to minimize the need for repeat interventions, there is growing preference for DES due to their ability to inhibit neointimal hyperplasia and promote long-term patency. This shift towards DES is expected to drive market growth in the Carotid Stents segment as healthcare providers seek to offer optimal therapeutic options for patients with carotid artery stenosis.
A key driver for the Carotid Stents market is the rising prevalence of carotid artery disease, primarily attributed to aging populations, sedentary lifestyles, and the increasing prevalence of risk factors such as hypertension, diabetes, and dyslipidemia. Carotid artery disease, characterized by the narrowing or blockage of the carotid arteries, poses a significant risk of ischemic stroke, a leading cause of mortality and long-term disability worldwide. As healthcare systems focus on early detection and effective management of carotid artery disease to prevent stroke-related morbidity and mortality, the demand for carotid stents as a minimally invasive treatment option is expected to increase, thereby fueling market growth in the Carotid Stents segment.
An opportunity for market expansion in the Carotid Stents segment lies in the development of innovative stent technologies and delivery systems that address the evolving needs of patients and clinicians. Advancements in stent design, including bioresorbable scaffolds, improved radial strength, and enhanced flexibility, can contribute to better clinical outcomes and reduced rates of complications such as stent fracture and restenosis. Additionally, innovations in delivery systems, such as next-generation catheters and navigation tools, can facilitate precise stent placement and optimize procedural efficiency. Companies investing in research and development of such technological advancements have the potential to differentiate their products in the market and capture a larger share of the growing demand for carotid stents. By leveraging emerging technologies and collaborating with healthcare providers, stakeholders can capitalize on this opportunity to improve patient care and drive innovation in the Carotid Stents market.
Among the options listed, self-expanding carotid stents stand out as the fastest-growing segment. Carotid stents are used in the treatment of carotid artery stenosis, a condition characterized by the narrowing of the carotid arteries due to the buildup of plaque. Self-expanding stents are designed to gradually expand and conform to the shape of the artery once deployed, providing support and maintaining vessel patency. This flexibility allows for precise placement and adaptation to the anatomical variations of the carotid arteries, resulting in improved procedural outcomes and reduced rates of complications such as restenosis. The growing preference for self-expanding stents can be attributed to their ease of deployment, reduced risk of vessel injury, and favorable long-term clinical outcomes compared to balloon-expandable stents. Hospitals, ambulatory surgical centers, and cardiac centers are key end-users where self-expanding carotid stents are utilized for the management of carotid artery stenosis. As the demand for minimally invasive treatment options for carotid artery disease continues to rise, the market for self-expanding carotid stents is expected to experience significant growth in the coming years.
By Material
Metals
Others
By Type
Self-Expanding Stents
Balloon-Expandable Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
Impulse Dynamics
Beijing Bomais Technology Development
Biotronik Se & Co. KG
Boston Scientific Corp
Cardinal Health
InspireMD
Medtronic Plc
MicroPort Scientific Corp
Shanghai Haoran Biotechnology Co. Ltd
Shanghai Hengfei Biological Technology Co. Ltd
Shanghai Zhenyu Biological Technology Co. Ltd
Terumo Corp
W. L. Gore & Associates
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Carotid Stents Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Carotid Stents Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Carotid Stents Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Carotid Stents Market Size Outlook, $ Million, 2021 to 2030
3.2 Carotid Stents Market Outlook by Type, $ Million, 2021 to 2030
3.3 Carotid Stents Market Outlook by Product, $ Million, 2021 to 2030
3.4 Carotid Stents Market Outlook by Application, $ Million, 2021 to 2030
3.5 Carotid Stents Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Carotid Stents Industry
4.2 Key Market Trends in Carotid Stents Industry
4.3 Potential Opportunities in Carotid Stents Industry
4.4 Key Challenges in Carotid Stents Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Carotid Stents Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Carotid Stents Market Outlook by Segments
7.1 Carotid Stents Market Outlook by Segments, $ Million, 2021- 2030
By Material
Metals
Others
By Type
Self-Expanding Stents
Balloon-Expandable Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
8 North America Carotid Stents Market Analysis and Outlook To 2030
8.1 Introduction to North America Carotid Stents Markets in 2024
8.2 North America Carotid Stents Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Carotid Stents Market size Outlook by Segments, 2021-2030
By Material
Metals
Others
By Type
Self-Expanding Stents
Balloon-Expandable Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
9 Europe Carotid Stents Market Analysis and Outlook To 2030
9.1 Introduction to Europe Carotid Stents Markets in 2024
9.2 Europe Carotid Stents Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Carotid Stents Market Size Outlook by Segments, 2021-2030
By Material
Metals
Others
By Type
Self-Expanding Stents
Balloon-Expandable Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
10 Asia Pacific Carotid Stents Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Carotid Stents Markets in 2024
10.2 Asia Pacific Carotid Stents Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Carotid Stents Market size Outlook by Segments, 2021-2030
By Material
Metals
Others
By Type
Self-Expanding Stents
Balloon-Expandable Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
11 South America Carotid Stents Market Analysis and Outlook To 2030
11.1 Introduction to South America Carotid Stents Markets in 2024
11.2 South America Carotid Stents Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Carotid Stents Market size Outlook by Segments, 2021-2030
By Material
Metals
Others
By Type
Self-Expanding Stents
Balloon-Expandable Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
12 Middle East and Africa Carotid Stents Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Carotid Stents Markets in 2024
12.2 Middle East and Africa Carotid Stents Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Carotid Stents Market size Outlook by Segments, 2021-2030
By Material
Metals
Others
By Type
Self-Expanding Stents
Balloon-Expandable Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Impulse Dynamics
Beijing Bomais Technology Development
Biotronik Se & Co. KG
Boston Scientific Corp
Cardinal Health
InspireMD
Medtronic Plc
MicroPort Scientific Corp
Shanghai Haoran Biotechnology Co. Ltd
Shanghai Hengfei Biological Technology Co. Ltd
Shanghai Zhenyu Biological Technology Co. Ltd
Terumo Corp
W. L. Gore & Associates
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Material
Metals
Others
By Type
Self-Expanding Stents
Balloon-Expandable Stents
By End-User
Hospitals
Ambulatory Surgical Centers
Cardiac Centers
The global Carotid Stents Market is one of the lucrative growth markets, poised to register a 7.5% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, Impulse Dynamics, Beijing Bomais Technology Development, Biotronik Se & Co. KG, Boston Scientific Corp, Cardinal Health, InspireMD, Medtronic Plc, MicroPort Scientific Corp, Shanghai Haoran Biotechnology Co. Ltd, Shanghai Hengfei Biological Technology Co. Ltd, Shanghai Zhenyu Biological Technology Co. Ltd, Terumo Corp, W. L. Gore & Associates
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume